Decheng Capital Global Life Sciences Fund IV, L.P. 13D and 13G filings for CG Oncology, Inc. Common stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:40 pm Purchase |
2024-12-31 | 13G | CG Oncology, Inc. Common stock CGON |
Decheng Capital Global Life Sciences Fund IV, L.P. | 6,371,669 8.400% |
912,859 (+16.72%) |
Filing |
| 2024-04-09 7:12 pm Purchase |
2024-01-29 | 13G | CG Oncology, Inc. Common stock CGON |
Decheng Capital Global Life Sciences Fund IV, L.P. | 5,458,810 8.200% |
400,000 (+7.91%) |
Filing |
| 2024-02-08 5:17 pm Purchase |
2024-01-29 | 13G | CG Oncology, Inc. Common stock CGON |
Decheng Capital Global Life Sciences Fund IV, L.P. | 5,058,810 7.600% |
5,058,810 (New Position) |
Filing |